Depression and Anxiety Trial, Recruiting NCT07118722 Sponsor: Massachusetts General Hospital Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07118722
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 or older
  • People who identify with one or more Black African nationalities or ethnic groups
  • People experiencing pain in muscles, joints, bones, or surrounding soft tissues that has lasted longer than 3 months and is rated above 4 out of 10 in severity
  • People with mild to moderate depression, based on a standard questionnaire score (PHQ-9) between 5 and 14
  • People who are fluent in English and able to read in English
  • People who are able and willing to attend both in-person and video sessions
  • People whose antidepressant medication type and dose have not changed in the 6 weeks before the screening appointment
  • People who are willing to give formal consent and follow the study requirements

Who may not be able to join:

  • People with moderately severe or severe depression, based on a standard questionnaire score (PHQ-9) of 15 or higher
  • People currently experiencing substance abuse or dependence
  • People with significant memory or thinking difficulties
  • People who have previously had more than 8 sessions of cognitive behavioural therapy (a structured talking therapy)
  • People with a history of formal mindfulness training, or who are currently receiving counselling more than once a month
  • People who have ever been diagnosed with, or are currently experiencing, psychosis
  • People who have had thoughts of suicide or self-harm within the past 90 days, including those identified during screening
  • People who are currently taking part in another behavioural clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tony V Pham, Massachusetts General Hospital

Phone: 617-800-9988

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The Credibility and Expectancy Questionnaire; The Client Satisfaction Questionnaire; Modified Patient Global Impression of Change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov